Ketamine-based drug approved for treating severe depression in the US A variant of the party drug Ketamine has been licensed in the US for treatment-resistant depression.
The decision comes as the European Medicines Agency (EMA) considers a similar application, which could see British patients given the powerful anaesthetic better known as an illegal club drug.
The US Food and Drink Administration (FDA) yesterday licensed the nasal spray for use by those who have already tried at least two medications for depression, without success. The Daily Telegraph
See also:
The decision comes as the European Medicines Agency (EMA) considers a similar application, which could see British patients given the powerful anaesthetic better known as an illegal club drug.
The US Food and Drink Administration (FDA) yesterday licensed the nasal spray for use by those who have already tried at least two medications for depression, without success. The Daily Telegraph
See also:
No comments:
Post a Comment